Apidra 100 Iu/ml 3 ml Cartridge

Apidra 100 Iu/ml 3 ml Cartridge

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Insulin Glulisine (100IU)

Expiry Date: 01/2028

Special offer

Buy at $81.53

$81.53

Inclusive of all taxes

5 Cartridge

About The Product

Fast-acting insulin used before meals.

Description

Apidra 100 lu/ ml 3 ml cartridge is a a rapid acting insulin, used to control blood sugar in patient with type 1 and type 2 diabetes mellitus. The medication active ingredient is Insulin Glulisine (100IU).

It acts by facilitating cellular glucose uptake, primarily in muscle and adiptose tissues and inhibiting hepatic glucose production, thereby lowering blood glucose level. This prescription based medication should be used under the guidance of a healthcare professional and follow strict timings to ensure safety of the treatment.

Indication

Maintaining blood sugar level

Common Side Effects

● Hypoglycemia (low blood glucose level)
● Injection site reactions (pain, swelling and redness)
● Rash
● Itching
● Upper respiratory tract infections
● Liposydtrophy (skin thickening)
● Feeling Hungary
● Visual disturbances
● Sweating

Dosage And Duration

  • Apidra 100IU should be taken 15 minutes before a meal or within 20 minutes after starting the meal.
  • Do not stop taking without the consultation of a doctor.
  • The dosage must be individualized based on the patient's blood sugar levels, meal composition and insulin requirements.
  • Include the medicine with healthy diet, regular exercise, and weight reduction by taking advice to the doctor.

Mechanism Of Action

Apidra cartridge is a form of insulin that control blood sugar (glucose). The medicine helps the glucose get into the cells, so the body can use it for energy.

This is a form of hormonal therapy which lowers blood sugar within 10- 20 minutes of injecting it and effects can last for 4-5 hours. By lowering sugar level helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage and nerve problems.

Safety Advice

Alcohol
Prescription from a doctor is required when consuming alcohol with Apidra 100IU cartridge,. Consult the healthcare professional before using it.
Driving
Apidra 100IU cartridge may decrease alertness, affect the vision, increase dizziness and the blood sugar becomes too low or high anytime. For more information consult the doctor before the using the Injection.
Pregnancy
Apidra 100IU cartridge is not safe during pregnancy as research indicates the risk of side effects in developing baby. Please consult the doctor.
Breast Feeding
Women who breastfeed their child should avoid using Apidra 100IU cartridge, data suggest that the medicine is passed from the breast milk which affect the baby health.
Kidney
Apidra 100IU cartridge is not safe for kidney patients, dose adjustment may be needed. Please consult the doctor.
Liver
Liver patients should avoid using Apidra 100IU cartridge as it may interrupt the liver function.

Faqs

Apidra 100IU cartridge is used to provide insulin to the blood sugar patients which have low and high glucose level.

References

• Mazzarino, M., Pernice, S., de la Torre, X., & Botrè, F. (2011).

A screening procedure for synthetic insulins by an HPLC-chip interfaced to a quadrupole time-of-flight mass spectrometer. In Recent advances in doping analysis (19) (pp.

148-151). Cologne: Sportverlag Straub. • Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A., & Schänzer, W.

(2006). Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography− tandem mass spectrometry.

Analytical chemistry, 78(6), 1897-1903. • Suárez-Casillas, P., Lora-Escobar, S. J., Montecatine-Alonso, E., Li, T., & Acosta-García, H.

(2025). Stability of thermolabile drugs at room temperature.

A review. Farmacia Hospitalaria. • Delhi, N., Delhi, N.

W., Delhi, W., Delhi, S. W., Delhi, S., & Delhi, S.

E. ONLINE SUPPLEMENTARY APPENDIX. • Dal, O.

H., & Sezer, A. D.

(2017). Analytical and Sales Data Comparison of Reference Product of Insulin Aspart and its Biosimilar in Turkey.

Marmara Pharmaceutical Journal, 21(3), 675-687. • Attjioui, H., Cheikh, A., Tebaa, A., Zerhouni, M. W., Aliat, Z., Mefetah, H., & Bouatia, M.

(2020). The rise of electronic commerce in healthcare: the need to ensure consumer safety.

Int J Pharm Sci Res, 11.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026